HealthEquity Inc (HQY)

Industry Health Information Services
This stock can be held in an Investment ISA and an Investment Account
Sell

$95.00

Buy

$102.94

arrow-down$-0.37 (-0.37%)

HealthEquity Inc is a technology-enabled services platform that empowers consumers to make healthcare saving and spending decisions. Its products & services include healthcare saving & spending platform, health savings accounts, and healthcare incentives.
Prices updated at 02 Jun 2025, 13:51 BST
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-down-0.32%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Health Information Services
Chairman
Dr. Stephen D. Neeleman, M.D.
CEO
Mr. Scott R. Cutler
Most recent earnings
31 Jan 2025
Fiscal year end
31 Jan 2025
Employees
3,120
Head office
15 West Scenic Pointe Drive
Draper
United States
84020
mobile
+1 801 727-1000
letter
rputnam@healthequity.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Adrian T. Dillon
Independent Director
0.11m--0.32m-
Ms. Evelyn S. Dilsaver
Independent Director
0.09m--0.31m-
Mr. Robert W. Selander
Chairman of the Board
0.18m--0.39m-
Dr. Stephen D. Neeleman, M.D.
Vice Chairman and Director
0.45m--2.89m-
Mr. James M. Lucania
Executive Vice President, Principal Accounting Officer and Chief Financial Officer
0.58m--5.58m-
Mr. Delano Ladd
Executive Vice President, General Counsel and Corporate Secretary
0.40m--3.35m-
Ms. Gayle Wellborn
Independent Director
0.09m--0.30m-
Mr. Scott R. Cutler
Director, President and Chief Executive Officer
0.06m0.65m-8.28m-
Ms. Debra McCowan
Independent Director
0.09m--0.30m-
Mr. Rajesh Natarajan
Independent Director
0.09m--0.30m-
Mr. Stuart B. Parker
Independent Director
0.08m--0.31m-
Mr. Elimelech Rosner
Executive Vice President and Chief Technology Officer
0.57m--4.95m-
Mr. Michael Henry Fiore
Executive Vice President and Chief Commercial Officer
0.47m--7.40m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
BlackRock Inc10,868,1000.02017-111387-1.01450130 Apr 202512.56
Vanguard Group Inc8,821,8380.01409-154253-1.71848730 Apr 202510.20
Wasatch Advisors LP7,234,0363.56666-279709-3.72263130 Apr 20258.36
BlackRock Fund Advisors6,601,2214.79457-313966-30 Apr 20257.63
Fidelity Management & Research Company LLC6,249,09511.45855-837636-30 Apr 20257.22

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
12 Dec 2024-Ms. Debra McCowan95.56477,8007,779--
12 Dec 2024-Mr. Stuart B. Parker96.702,347,06619,789--
12 Dec 2024-Mr. Stuart B. Parker97.3070,83419,061--
12 Dec 2024-Mr. Elimelech Rosner97.12278,63557,195--
09 Dec 2024-Mr. Robert W. Selander-----
09 Dec 2024-Mr. Robert W. Selander101.56583,94366,469--
09 Dec 2024-Mr. Robert W. Selander21.27159,52573,969--
09 Dec 2024-Mr. Robert W. Selander28.68358,50072,219--
09 Dec 2024-Mr. Robert W. Selander101.57253,91771,469--
09 Dec 2024-Mr. Robert W. Selander--25,000--
06 Nov 2024-Mr. Frank A. Corvino96.1099,8483,784--
11 Oct 2024-Dr. Stephen D. Neeleman, M.D.--553,235--
09 Oct 2024-Mr. Robert W. Selander--7,500--
09 Oct 2024-Mr. Robert W. Selander--37,500--
09 Oct 2024-Mr. Robert W. Selander83.34145,67559,719--
09 Oct 2024-Mr. Robert W. Selander82.2761,87061,467--
09 Oct 2024-Mr. Robert W. Selander21.27159,52562,219--
09 Oct 2024-Mr. Robert W. Selander83.776,28354,719--
09 Oct 2024-Mr. Robert W. Selander83.27347,31254,794--
09 Oct 2024-Mr. Robert W. Selander82.07123,43858,965--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.